InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Blanchard Cheryl R, Présidente et Directrice Générale. Director active across 3 companies, notably Anika Therapeutics, Inc.. In total, 16 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €99k. Activity tracked since 15 June 2021. The latest transaction was filed on 22 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Blanchard Cheryl R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
24,519 股Common StockSEC:0001193125-26-111494:0
20,001 股Common StockSEC:0001193125-26-102239:0
5,000 股Common StockSEC:0000950170-25-102476:0
5,000 股0Common StockSEC:0000950170-25-077268:0
25,132 股0Common StockSEC:0001171843-25-001531:0
30,060 股0Common StockSEC:0001171843-25-001467:0
5,871 股@ US$16.6252.1% 占其流量Common StockSEC:0001171843-25-001404:1
20,002 股0Common StockSEC:0001171843-25-001404:0
14,420 股0Common StockSEC:0001171843-24-001307:0
24,575 股0Common StockSEC:0001171843-23-002685:0
30,060 股0Common StockSEC:0001171843-23-001684:0
14,419 股0Common StockSEC:0001171843-23-001595:0
24,576 股0Common StockSEC:0001171843-22-002980:0
4,287 股@ US$25.35954.5% 占其流量Common StockSEC:0001171843-22-001833:0
标准退出：2022年6月9日 (T+90)
14,420 股0Common StockSEC:0001171843-22-001809:0
2,994 股@ US$33.4045.5% 占其流量Common StockSEC:0001171843-21-004397:0
16 条申报中的 16 条
About Blanchard Cheryl R
Cheryl R Blanchard is President and Chief Executive Officer. She has 16 filings in total, and across the sampled recent filings from 2021-06-17 to 2026-03-17, buys total EUR 98706 and sells EUR 0, with the most common transaction nature shown as option exercise. Her filings concern Anika Therapeutics, Inc. and Vigil Neuroscience, Inc.
